Ali Shultz’s firsthand experience with hospital COVID-19 treatment protocols ignited her effort to help those who have found themselves being treated as experimental subjects that bring in federal reimbursements, rather than patients.
“It’s not so much a protocol as it’s a modus operandi,” Shultz told The Epoch Times.
